1. Home
  2. CNM vs RGEN Comparison

CNM vs RGEN Comparison

Compare CNM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core & Main Inc.

CNM

Core & Main Inc.

HOLD

Current Price

$55.96

Market Cap

9.0B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$157.57

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNM
RGEN
Founded
1996
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CNM
RGEN
Price
$55.96
$157.57
Analyst Decision
Buy
Buy
Analyst Count
11
10
Target Price
$60.82
$170.90
AVG Volume (30 Days)
3.2M
724.0K
Earning Date
12-09-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
7.81
N/A
EPS
2.28
0.03
Revenue
$7,764,000,000.00
$707,890,000.00
Revenue This Year
$4.45
$17.84
Revenue Next Year
$4.43
$12.57
P/E Ratio
$24.64
$5,097.58
Revenue Growth
8.09
11.74
52 Week Low
$43.18
$102.97
52 Week High
$67.18
$182.52

Technical Indicators

Market Signals
Indicator
CNM
RGEN
Relative Strength Index (RSI) 70.80 47.50
Support Level $44.59 $160.11
Resistance Level $50.10 $165.02
Average True Range (ATR) 1.68 4.97
MACD 1.17 -1.27
Stochastic Oscillator 90.74 7.12

Price Performance

Historical Comparison
CNM
RGEN

About CNM Core & Main Inc.

Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: